# FDA 483 - New Jersey Laboratories - May 12, 2026

Source: https://www.keypedia.com/records/483/new-jersey-laboratories/3a492ceb-be50-432c-b2f7-8e6fcdefcac2

> FDA 483 for New Jersey Laboratories on May 12, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: New Jersey Laboratories
- Inspection Date: 2026-05-12
- Product Type: drugs
- Office Name: FDA District Office — Parsippany, New Jersey
- Summary: New Jersey Laboratories, a control laboratory in New Brunswick, NJ, was inspected by the FDA, revealing two observations. The firm failed to include sample dates in laboratory records for microbial content testing and lacked written cleaning and maintenance schedules for equipment used in sterility testing. These issues indicate deficiencies in record-keeping and facility maintenance procedures.

## Related Documents

- [EIR - 2022-09-22](https://www.keypedia.com/records/eir/new-jersey-laboratories/8e00354b-15a3-43ca-bf1e-48ee075bde3c)
- [483 - 2022-09-22](https://www.keypedia.com/records/483/new-jersey-laboratories/b713587b-7449-4ee8-91d3-e8123584384a)

## Related Officers

- [Advisor](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/new-jersey-laboratories/d310e635-49c8-4881-97d4-757fe831e691

Office: https://www.keypedia.com/offices/fda-district-office-parsippany-new-jersey/d0f9de06-c0ec-4c7a-bce9-c6c0496b7de7